StonvexLoading…
StonvexStonvexStonvexCore line items from PSX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-23 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $44.73B | $32.54B | $132.38B | $98.27B | $63.75B |
Operating Income | Not available | Not available | Not available | Not available | Not available |
Net Income | Not available | $207.00M | $4.40B | $1.50B | $1.36B |
EPS (Diluted) | $6.34 | $0.51 | $10.79 | $3.66 | $3.32 |
Total Assets | Not available | $84.08B | $73.68B | $76.12B | $75.94B |
Total Liabilities | Not available | $54.40B | $43.44B | $48.04B | $47.31B |
Cash & Equivalents | Not available | $5.15B | $1.12B | $1.84B | $1.05B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | 403.27M | 408.05M | 407.88M | 409.45M |